The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthma.
about
Cathelicidin impact on inflammatory cellsAntiviral potential of cathelicidinsThe internal architecture of leukocyte lipid body organelles captured by three-dimensional electron microscopy tomographyActivation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic AsthmaUnraveling the complexity of lipid body organelles in human eosinophils.Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory epithelium inflammation in a mouse model.Mechanisms and potential therapeutic targets in allergic inflammation: recent insights.Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37.LEAP-2, LL-37 and RNase7 in tonsillar tissue: downregulated expression in seasonal allergic rhinitis.Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c mice.Neutrophil extracellular traps are associated with inflammation in chronic airway disease.Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells.Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation.Chronic features of allergic asthma are enhanced in the absence of resistin-like molecule-beta.
P2860
Q26777983-48FCB5E0-DAB9-49BB-B757-63A75A775622Q27006576-B73D05B5-9224-4FBD-BE56-D94BBFF7F3E7Q27333495-C3F5842E-36C9-4AFB-97A7-1714846C30FDQ33687420-74D9FA97-AA8E-4665-8E95-633BD63B390AQ34341337-44DE5E6C-0E3E-4098-8BB0-00C8FFBA3B0FQ37656026-E2CF0E20-96BF-4B79-9FCB-B4EEFBD50953Q38161574-110281C5-983D-4A6A-8559-DF0839F0EADCQ38588798-42AB7F32-8F80-4162-836B-05BBC1969E92Q42019549-A3BDC68C-2280-4F3E-A023-8AE54F84968AQ42219114-DD9286D3-DDB8-470B-90C1-65A1815823F1Q47429893-04178E73-4735-498A-8121-62D5B2E98235Q47895635-EFFD4533-84C6-449F-99B1-406780270FD7Q55010741-470E05DB-C7BC-4C7A-8CB6-7CED0B0506A5Q55082789-676FA7BB-C741-4A18-BCD8-EFA98870DD95Q55102151-2CE88376-A080-4387-B846-044180E633AF
P2860
The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The antimicrobial peptide LL-3 ...... hils--implications for asthma.
@en
The antimicrobial peptide LL-3 ...... hils--implications for asthma.
@nl
type
label
The antimicrobial peptide LL-3 ...... hils--implications for asthma.
@en
The antimicrobial peptide LL-3 ...... hils--implications for asthma.
@nl
prefLabel
The antimicrobial peptide LL-3 ...... hils--implications for asthma.
@en
The antimicrobial peptide LL-3 ...... hils--implications for asthma.
@nl
P2093
P2860
P356
P1433
P1476
The antimicrobial peptide LL-3 ...... hils--implications for asthma.
@en
P2093
P2860
P304
P356
10.1111/ALL.12087
P577
2013-01-18T00:00:00Z